
Cargo agrees to Concentra buyout after trial setback, layoffs
Dive Brief: Cell therapy developer Cargo Therapeutics has, after halting its drug development and laying off nearly all its staff earlier this year, agreed to be bought by Concentra Biosciences, a hedge fund-backed acquirer of distressed biotechnology …